FDA Approval and Access Strategy for Lenacapavi...

By Rene Pretorius

June 20, 2025

Summary The FDA has approved Yeztugo (lenacapavir), a revolutionary twice-yearly injection that redefines ...
Canada Launches Consultation for Essential Prescription Drugs List
ACIP Vaccine Policy Concerns
NICE Rejects Donanemab: Treatment Cost-Effectiveness
Efficacy of Ultomiris Pediatric TMA Treatment
How Gene-Editing Therapies Are Revolutionizing ASCVD Treatment and Market Tra...
EMA 2024 Report Highlights: Innovations in Medicine Approval and Regulatory A...
PCV20 Reimbursement Guidelines: Analysis of Dutch Advisory Council Recommenda...
NICE Approves Transformative Multiple Myeloma Treatment
KEYTRUDA Head Neck Cancer Approval: Transforming Treatment and Health Economics
Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implic...
Advancements in HIV Vaccine Trials: Promising Results from mRNA Strategies
EHK Clusters 2026 Report: Enhancements in Dutch Risk Equalization for High-Co...